Exact Sciences
EXAS
#1152
Rank
โ‚น1.743 T
Marketcap
โ‚น9,190
Share price
0.43%
Change (1 day)
92.05%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): -โ‚น456.52

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -โ‚น480.16. In 2024 the company made an earnings per share (EPS) of -โ‚น502.72.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น456.52-9.19%
2024-โ‚น502.72
2022-โ‚น319.512.31%
2021-โ‚น312.29-38.54%
2020-โ‚น508.14692.96%
2019-โ‚น64.08-50.69%
2018-โ‚น129.9744%
2017-โ‚น90.26-39.39%
2016-โ‚น148.92-2.94%
2015-โ‚น153.4337.1%
2014-โ‚น111.9279.71%
2013-โ‚น62.28-21.59%
2012-โ‚น79.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
-โ‚น390.81-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚น30.69-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
โ‚น35.20-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น4,594 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น334.46-169.66%๐Ÿ‡ซ๐Ÿ‡ท France